4CPS-030 Evaluation of pharmacist-led cardiovascular services within primary care, provided by cardiovascular pharmacists. (2nd March 2018)

• Record Type: Journal Article
• Authors: Koch, K; Meddings, C; Collings, V; Bidad, N
• Is Part Of: European journal of hospital pharmacy. Volume 25(2018)Supplement 1
• Page Start: A55
• Page End: A55
• Publication Date: 2018-03-02
• Subjects: Pharmacy -- Periodicals; Hospital pharmacies -- Periodicals; 615.1
• DOI: 10.1136/ejhpharm-2018-eahpconf.121
• Languages: English
• ISSNs: 2047-9956

Abstract

Abstract : Background: There is a limited amount of evidence demonstrating the benefit of pharmacy-led community services managing cardiovascular diseases. With an ever increasing demand on hospitals and a focus on preventing admission, the cardiovascular pharmacy team at a hospital is delivering both virtual clinics and pharmacist-led hypertension and lipid clinics with an overall aim of reducing cardiovascular disease risk factors for patients within primary care. Purpose: The aim of this report was to identify and evaluate the pharmacist-led cardiovascular services provided within primary care from June 2016 (when the new services were started) to July 2017. Material and methods: Retrospective data for all patients seen within the pharmacist-led clinics and hypertension virtual clinics and all returned surveys were included in this service evaluation. Results: A total of 65 patients from the hypertension virtual clinic were reviewed. There were 108 pharmacists' interventions made and 51 patients were followed-up after 6 months. Blood pressure was recorded at 6 months for 34 patients and a mean systolic blood pressure decline of −18 (±18.0) mmHg was observed. There were 26 patients who had a systolic blood pressure >160 mm/Hg compared with three patients after 6 months. A total of 17 patients have been seen in the pharmacist-led clinics; of which six patients have had follow-up recordings. A mean systolic blood pressure decline of −23 (±2.0) mmHg was achieved for three patients and a mean non-HDL decline of −1.61 (±0.69) mmol/l was achieved in three patients. The satisfaction of service users was stated as high in the returned surveys. Conclusion: Due to small numbers of patients, statistical significance could not be calculated. However, the available data shows an overall positive trend in patient outcomes and high satisfaction rating. References and/or Acknowledgements: I want to thank the staff of University College London and Guy's and St. Thomas' NHS Foundation Trust for their help, support and collaboration. No conflict of interest